These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Differential response patterns to MAO inhibitors and tricyclics. Nies A J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):70-7. PubMed ID: 6376487 [TBL] [Abstract][Full Text] [Related]
3. Tricyclic antidepressants and monoamine oxidase inhibitors in the treatment of agoraphobia. Pohl R; Berchou R; Rainey JM J Clin Psychopharmacol; 1982 Dec; 2(6):399-407. PubMed ID: 7174863 [TBL] [Abstract][Full Text] [Related]
4. Successful use of clonazepam in patients with treatment-resistant panic disorder. Tesar GE; Rosenbaum JF J Nerv Ment Dis; 1986 Aug; 174(8):477-82. PubMed ID: 3734770 [TBL] [Abstract][Full Text] [Related]
5. Platelet imipramine binding in patients with posttraumatic stress disorder before and after phenelzine treatment. Weizman R; Laor N; Schujovitsky A; Wolmer L; Abramovitz-Schnaider P; Freudstein-Dan A; Rehavi M Psychiatry Res; 1996 Jul; 63(2-3):143-50. PubMed ID: 8878310 [TBL] [Abstract][Full Text] [Related]
6. A review of the psychopharmacology of panic disorder: individual differences and non specific factors. Cox BJ; Swinson RP; Endler NS Can J Psychiatry; 1991 Mar; 36(2):130-8. PubMed ID: 2044033 [TBL] [Abstract][Full Text] [Related]
7. The use of psychotropic drugs in the treatment of compulsive opiate abusers: the rationale for their use. Kleber HD Adv Alcohol Subst Abuse; 1985 Fall-1986 Winter; 5(1-2):103-19. PubMed ID: 2870623 [TBL] [Abstract][Full Text] [Related]
8. Forms of atypical depression and their response to antidepressant drugs. Davidson J; Pelton S Psychiatry Res; 1986 Feb; 17(2):87-95. PubMed ID: 3083445 [TBL] [Abstract][Full Text] [Related]
9. The dexamethasone suppression test in panic disorder and agoraphobia. Curtis GC; Cameron OG; Nesse RM Am J Psychiatry; 1982 Aug; 139(8):1043-6. PubMed ID: 7091428 [TBL] [Abstract][Full Text] [Related]
10. Platelet monoamine oxidase activity and behavioral response to pharmacotherapy in psychiatric patients. Rosen AJ; Wirtshafter D; Pandey GN; Davis JM Psychiatry Res; 1982 Feb; 6(1):49-59. PubMed ID: 6120529 [TBL] [Abstract][Full Text] [Related]
11. Panic attacks. A review of treatments and pathogenesis. Grunhaus L; Gloger S; Weisstub E J Nerv Ment Dis; 1981 Oct; 169(10):608-13. PubMed ID: 6116741 [TBL] [Abstract][Full Text] [Related]
12. Antidepressant specificity in atypical depression. Liebowitz MR; Quitkin FM; Stewart JW; McGrath PJ; Harrison WM; Markowitz JS; Rabkin JG; Tricamo E; Goetz DM; Klein DF Arch Gen Psychiatry; 1988 Feb; 45(2):129-37. PubMed ID: 3276282 [TBL] [Abstract][Full Text] [Related]
15. The drug treatment of anxiety and depression. Cole JO Med Clin North Am; 1988 Jul; 72(4):815-30. PubMed ID: 3287039 [TBL] [Abstract][Full Text] [Related]
16. Drugs for psychiatric disorders. Med Lett Drugs Ther; 1976 Oct; 18(22):89-96. PubMed ID: 10519 [No Abstract] [Full Text] [Related]
17. Phenelzine v imipramine in atypical depression. A preliminary report. Liebowitz MR; Quitkin FM; Stewart JW; McGrath PJ; Harrison W; Rabkin J; Tricamo E; Markowitz JS; Klein DF Arch Gen Psychiatry; 1984 Jul; 41(7):669-77. PubMed ID: 6375621 [TBL] [Abstract][Full Text] [Related]